BCAX Annual CFI
-$586.00 K
-$394.00 K-205.21%
01 December 2023
Summary:
As of January 23, 2025, BCAX annual cash flow from investing activities is -$586.00 thousand, with the most recent change of -$394.00 thousand (-205.21%) on December 1, 2023. During the last 3 years, it has fallen by -$394.00 thousand (-205.21%). BCAX annual CFI is now -205.21% below its all-time high of -$192.00 thousand, reached on December 1, 2022.BCAX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Quarterly CFI
-$8000.00
0.00%
30 September 2024
Summary:
As of January 23, 2025, BCAX quarterly cash flow from investing activities is -$8000.00Over the past year, it has increased by +$142.00 thousand (+94.67%). BCAX quarterly CFI is now at all-time high.BCAX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX TTM CFI
-$8000.00
0.00%
30 September 2024
Summary:
As of January 23, 2025, BCAX TTM cash flow from investing activities is -$8000.00Over the past year, it has increased by +$142.00 thousand (+94.67%). BCAX TTM CFI is now at all-time high.BCAX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -205.2% | +94.7% | +94.7% |
3 y3 years | -205.2% | +94.7% | +94.7% |
5 y5 years | -205.2% | +94.7% | +94.7% |
BCAX Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -205.2% | at low | at high | +94.7% | at high | +94.7% |
5 y | 5-year | -205.2% | at low | at high | +94.7% | at high | +94.7% |
alltime | all time | -205.2% | at low | at high | +94.7% | at high | +94.7% |
Bicara Therapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$8000.00(-94.7%) | -$8000.00(-94.7%) |
Dec 2023 | -$586.00 K | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$150.00 K | -$150.00 K |
Dec 2022 | -$192.00 K | - | - |
FAQ
- What is Bicara Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Bicara Therapeutics?
- What is Bicara Therapeutics annual CFI year-on-year change?
- What is Bicara Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly CFI year-on-year change?
- What is Bicara Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bicara Therapeutics?
- What is Bicara Therapeutics TTM CFI year-on-year change?
What is Bicara Therapeutics annual cash flow from investing activities?
The current annual CFI of BCAX is -$586.00 K
What is the all time high annual CFI for Bicara Therapeutics?
Bicara Therapeutics all-time high annual cash flow from investing activities is -$192.00 K
What is Bicara Therapeutics annual CFI year-on-year change?
Over the past year, BCAX annual cash flow from investing activities has changed by -$394.00 K (-205.21%)
What is Bicara Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BCAX is -$8000.00
What is the all time high quarterly CFI for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly cash flow from investing activities is -$8000.00
What is Bicara Therapeutics quarterly CFI year-on-year change?
Over the past year, BCAX quarterly cash flow from investing activities has changed by +$142.00 K (+94.67%)
What is Bicara Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BCAX is -$8000.00
What is the all time high TTM CFI for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM cash flow from investing activities is -$8000.00
What is Bicara Therapeutics TTM CFI year-on-year change?
Over the past year, BCAX TTM cash flow from investing activities has changed by +$142.00 K (+94.67%)